NCT05580445 2023-11-22
Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer
Shouyao Holdings (Beijing) Co. LTD
Phase 1/2 Unknown
Clinical Trials
14 trialsNCT04931381 2022-08-02
Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer
Changhai Hospital
Phase 3 Unknown
NCT05438797 2022-06-30
The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer
Jinling Hospital, China
Phase EARLY_PHASE1 Unknown
NCT05298020 2022-03-28
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 2 Unknown
NCT05162118 2022-03-09
Clinical Study of VG161 in Combination With Nivolumab in Subjects With Advanced Pancreatic Cancer
Zhejiang University
Phase 1/2 Unknown
NCT05100329 2021-10-29
A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
NCT04928625 2021-08-24
A Trial of SHR-A1904 in Patients With Advanced Pancreatic Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04707118 2021-01-13
Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy
Fudan University
Phase 1 Unknown
NCT04482257 2020-07-22
Bioequivalence Study of Irinotecan Liposome Injection in Chinese Advanced Pancreatic Cancer.
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT04239001 2020-01-23
Efficacy and Safety of Pegylated Recombinant Human Granulocyte Stimulating Factor in Secondary Prevention of Albumin Paclitaxel Combined With S-1 in the First-line Treatment of Advanced Pancreatic Cancer
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Phase NA Unknown
NCT04217096 2020-01-03
Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients
Fudan University
Phase 4 Unknown
NCT03662035 2018-09-19
ASPC
Changzhou No.2 People's Hospital
Phase 2 Unknown
NCT02124317 2016-12-22
NAPSPAC
Chinese PLA General Hospital
Phase 2 Unknown
NCT02135822 2014-05-16
NAPGAP
Chinese PLA General Hospital
Phase 2 Unknown